Sarah J Fritchley, PhD
Chief Development Officer
Sarah joined Mission Therapeutics in June 2024.
Sarah, a Pharmacology graduate with a PhD in Immunology, has 25 years of biotech industry experience which began in preclinical translational science and transitioned to clinical development. Her experience spans a wide range of therapeutic areas, in various phases of clinical trials within biotech, mid-sized and large pharma and global CRO.
Sarah has held broad leadership roles in clinical, regulatory and overall development strategy, and operational management.
